UnknownPhase 3NCT02686151

The Letrozole Administration During Luteal Phase

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: The Affiliated Hospital of Inner Mongolia Medical University
Principal Investigator: Yu Wang, PhD
Inner Mongolia Medical University affiliated Hospital
Intervention: Letrozole(drug)
Enrollment: 50 target
Eligibility: 20-40 years · FEMALE
Timeline: 2023 – 2024

Study locations (1)

The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02686151 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials